Not sure how STAT played this on their site. In the the print version of The Boston Globe, it ran it on A1 Thursday Hopes rise again for a drug to slow Alzheimer’s disease The follow-up in today's print edition ran on B12, with this headline: Interpreting an Alzheimer's trial. Have yet to find in on … Continue reading Alzheimer’s drug promising? Page 1. Alzheimer’s drug not so promising? Page B12
The exclamation point is a red flag. Editors tell freelance writers to read the publication before pitching a stories. I guess the stakes are lower for PR email blasts. Below find a sample from senders the BHN directs to the trash. A few good ones get caught up in the screen. (Here's some help on … Continue reading The health press releases that go straight to the junk folder. Some good ideas with no Boston link. Lots of true junk!
Now that BostonGlobe.com and Boston.com have gotten divorced, don't expect to see Globe bylines on Boston.com health page. The health blogs don't seem to be over there anymore either. But, it's a beta site and we hear they are still dividing the property. Chelsea Conaboy, who did a nice job with both White Coat Notes … Continue reading Health sites evolve as Boston.com and BostonGlobe.com split up property
A WBUR host on fundraising duty this morning talked about how NIH has figured out a way around the federal shutdown to get a so-called life-saving treatment to a Cape Cod man in a drug study. The fact is, if you are in a clinical trial, no one can promise that you are getting a … Continue reading Therapeutic misconception: Reporting on the Cape Cod clinical trial participant